Activity
-
Increasing awareness about Sickle Cell Disease and our efforts Pfizer to develop new therapies is my North Star. #SickleCellDisease
Increasing awareness about Sickle Cell Disease and our efforts Pfizer to develop new therapies is my North Star. #SickleCellDisease
Liked by Pierre Kiami
-
This week Structure Therapeutics welcomed a dynamic group of interns from around the world, and we have a fantastic lineup of exciting activities and…
This week Structure Therapeutics welcomed a dynamic group of interns from around the world, and we have a fantastic lineup of exciting activities and…
Liked by Pierre Kiami
More activity by Pierre
-
The data is clear – increased representation of Black healthcare providers and leaders in the pharmaceutical industry leads to better health outcomes…
The data is clear – increased representation of Black healthcare providers and leaders in the pharmaceutical industry leads to better health outcomes…
Liked by Pierre Kiami
-
Our CEO Raymond Stevens recently spoke with CNBC Fast Money's Melissa Lee to discuss our progress with our #GLP1 receptor agonist drug, GSBR-1290…
Our CEO Raymond Stevens recently spoke with CNBC Fast Money's Melissa Lee to discuss our progress with our #GLP1 receptor agonist drug, GSBR-1290…
Liked by Pierre Kiami
-
We're pleased to share positive topline data from our 12-week Phase 2a #obesity study of our oral, non-peptide GLP-1 receptor agonist, GSBR-1290…
We're pleased to share positive topline data from our 12-week Phase 2a #obesity study of our oral, non-peptide GLP-1 receptor agonist, GSBR-1290…
Liked by Pierre Kiami
-
We're pleased to share financial results and recent corporate achievements for the first quarter of 2024 as well as upcoming plans to share topline…
We're pleased to share financial results and recent corporate achievements for the first quarter of 2024 as well as upcoming plans to share topline…
Liked by Pierre Kiami
-
We are profoundly grateful this day has arrived. After decades of waiting for a new treatment for sickle cell disorder, NICE’s (National Institute…
We are profoundly grateful this day has arrived. After decades of waiting for a new treatment for sickle cell disorder, NICE’s (National Institute…
Liked by Pierre Kiami
-
If a child can become a parent’s whole world, think of all the worlds Dr. Marilyn Hughes Gaston has changed. Nearly 40 years ago, her research on…
If a child can become a parent’s whole world, think of all the worlds Dr. Marilyn Hughes Gaston has changed. Nearly 40 years ago, her research on…
Liked by Pierre Kiami
-
I am so honored to have been able to meet and interview this exemplary CEO, Ted W. Love, MD for Forbes. The fact that it's Black History Month is…
I am so honored to have been able to meet and interview this exemplary CEO, Ted W. Love, MD for Forbes. The fact that it's Black History Month is…
Liked by Pierre Kiami
-
What a privilege it was to be interviewed by Shimité O.é for Forbes. The honor is truly mine! Thank you, Shimité, and thank you to everyone who has…
What a privilege it was to be interviewed by Shimité O.é for Forbes. The honor is truly mine! Thank you, Shimité, and thank you to everyone who has…
Liked by Pierre Kiami
-
There’s a disconnect between who pharma is as an industry and how the general public perceives us. I saw this firsthand during a conversation with my…
There’s a disconnect between who pharma is as an industry and how the general public perceives us. I saw this firsthand during a conversation with my…
Liked by Pierre Kiami
-
Clouds North Films has rescheduled (due to inclement weather last week) to speak this week at 1 Million Cups, a networking event for entrepreneurs…
Clouds North Films has rescheduled (due to inclement weather last week) to speak this week at 1 Million Cups, a networking event for entrepreneurs…
Liked by Pierre Kiami
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More